Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,302,581
+$71,009 QoQ
Shares Held
1,086
-18.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,888
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Scharf Investments, LLC holds $50,013,977 across 2 Drug Manufacturers - General names. LLY ranks #2 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
310,818 | $48,711,396 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
1,086 | $1,302,581 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,302,581 | 1,086 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,231,572 | 1,339 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,217,065 | 2,063 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,864,772 | 2,444 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,934,013 | 2,481 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,875,641 | 2,271 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,729,280 | 2,240 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,323,594 | 1,494 | Shares | Sole | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||